Skip to main content
European Commission logo
Deutsch Deutsch
CORDIS - Forschungsergebnisse der EU
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary
Inhalt archiviert am 2024-05-30

Potential Antimalarial and Anticancer Lead Compound Discovery from Cameroonian Medicinal Plants

Ziel

Cameroon enjoys a rich biota including a plethora of medicinal plants, which have traditionally been used for hundreds of
years to treat various ailments, and form the basis of the country’s primary healthcare system. Medicinal plants of the
genera Fagara (F: Rutaceae), and Hannoa and Pierreodendron (F: Simaroubaceae) belong to the Cameroonian flora, and
are used by the local people to treat malaria, cancer, rheumatism, bacterial infections, pain, inflammations, typhoid, skin
infection and other serious disorders. Previous studies carried out on certain species of these genera afforded various
phytochemicals (quassinoids, furoquinoleine, acridones, cathinone alcaloids, triterpenoids and steroids) and revealed
interesting pharmacological properties (cytotoxicity, antiplasmadial activities). This project proposes to employ a
combination of chemical fingerprinting-based dereplication, assay-guided fractionation and reversed-phase preparative high
performance chromatographic methods to identify potential anticancer and antimalarial lead compounds from plants of the
genera mentioned above, selected on the basis of ethnobotanical information as well as literature data. The structures of
the isolated compounds will be elucidated by spectroscopic means (UV, IR, MS, NMR and X-ray). Structural modification to
increase activity of compounds will be carried out applying modern semisynthetic approaches in order to establish structureactivity
relationships. Total synthesis will also be carried out to increase to quantity of the lead compounds. Suitable in vitro
bioassays, relevant to cytotoxicity, antimalarial and toxicity determination will be utilised to aid isolation processes as well as
for the determination of bioactive potencies of the isolated lead compounds. The main objective is to discover and develop
bioactive natural products and their analogues as clinical trial candidates.

Aufforderung zur Vorschlagseinreichung

FP7-PEOPLE-2013-IIF
Andere Projekte für diesen Aufruf anzeigen

Koordinator

UNIVERSITE DE DOUALA
EU-Beitrag
€ 15 000,00
Adresse
CARREFOUR ANGE RAPHAEL
00237 Douala
Kamerun

Auf der Karte ansehen

Aktivitätstyp
Higher or Secondary Education Establishments
Kontakt Verwaltung
Ndom Jean Claud (Prof.)
Links
Gesamtkosten
Keine Daten